Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.55B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.19B |
| 3 |
iShares Silver Trust
SLV
|
+$1.03B |
| 4 |
Walmart Inc
WMT
|
+$862M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$850M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.99B |
| 2 |
Micron Technology
MU
|
+$1.09B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$772M |
| 4 |
Tesla
TSLA
|
+$700M |
| 5 |
Direxion Daily Semiconductor Bull 3X ETF
SOXL
|
+$639M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.77% |
| 2 | Healthcare | 1.08% |
| 3 | Consumer Discretionary | 1.03% |
| 4 | Financials | 0.94% |
| 5 | Communication Services | 0.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5001
Spire
SR
$4.96B
| $1.81M | ﹤0.01% |
21,849
+11,753
| +116% | +$1M |
|
5002
PUT
Flutter Entertainment
FLUT
$17.2B
| $1.8M | ﹤0.01% |
8,300
+1,200
| +17% | +$270K |
|
|
MDLN
5003
CALL
Medline Inc
MDLN
$29.7B
| $1.8M | ﹤0.01% |
+42,900
| New | +$1.81M |
|
|
CATF
5004
American Century California Municipal Bond ETF
CATF
$81.9M
| $1.8M | ﹤0.01% |
36,021
-7,514
| -17% | -$376K |
|
5005
PUT
Vanguard World Funds Extended Duration ETF
EDV
$3.5B
| $1.8M | ﹤0.01% |
27,700
-5,800
| -17% | -$395K |
|
5006
First Trust RiverFront Dynamic Developed International ETF
RFDI
$168M
| $1.8M | ﹤0.01% |
22,364
-9,106
| -29% | -$712K |
|
5007
CALL
Kinsale Capital Group
KNSL
$8.66B
| $1.8M | ﹤0.01% |
4,600
-13,200
| -74% | -$5.38M |
|
|
SLNZ
5008
TCW Senior Loan ETF
SLNZ
$223M
| $1.8M | ﹤0.01% |
38,839
+31,007
| +396% | +$1.45M |
|
|
NEE.PRS
5009
NextEra Energy 7.299% Corporate Units
NEE.PRS
$2.11B
| $1.8M | ﹤0.01% |
34,716
-12,945
| -27% | -$688K |
|
|
ONT
5010
Onterris Inc
ONT
$582M
| $1.8M | ﹤0.01% |
72,363
-331,015
| -82% | -$8.74M |
|
5011
Amplify International Enhanced Dividend Income ETF
IDVO
$1.39B
| $1.8M | ﹤0.01% |
46,843
-43,493
| -48% | -$1.64M |
|
|
JKS
5012
PUT
JinkoSolar
JKS
$886M
| $1.8M | ﹤0.01% |
69,600
+3,500
| +5% | +$89.3K |
|
5013
PUT
iShares Preferred and Income Securities ETF
PFF
$13.2B
| $1.8M | ﹤0.01% |
58,000
+44,900
| +343% | +$1.4M |
|
5014
Iridium Communications
IRDM
$5.17B
| $1.8M | ﹤0.01% |
103,282
-401,252
| -80% | -$7.09M |
|
5015
CALL
Infosys
INFY
$49.4B
| $1.79M | ﹤0.01% |
100,600
+3,200
| +3% | +$55.4K |
|
5016
CALL
Kymera Therapeutics
KYMR
$10.3B
| $1.79M | ﹤0.01% |
23,000
+11,200
| +95% | +$756K |
|
|
PPL
5017
PUT
PPL Corp
PPL
$26.6B
| $1.79M | ﹤0.01% |
51,100
-64,200
| -56% | -$2.31M |
|
5018
CALL
WesBanco
WSBC
$3.98B
| $1.79M | ﹤0.01% |
53,800
+15,900
| +42% | +$514K |
|
5019
PUT
Icon
ICLR
$13.2B
| $1.79M | ﹤0.01% |
9,800
+3,000
| +44% | +$534K |
|
5020
Shift4
FOUR
$3.78B
| $1.79M | ﹤0.01% |
28,355
-91,943
| -76% | -$6.5M |
|
5021
CALL
Arcus Biosciences
RCUS
$3.87B
| $1.78M | ﹤0.01% |
74,900
-19,000
| -20% | -$388K |
|
5022
CALL
Ultragenyx Pharmaceutical
RARE
$2.59B
| $1.78M | ﹤0.01% |
77,500
-50,400
| -39% | -$1.66M |
|
5023
RE/MAX Holdings
RMAX
$302M
| $1.78M | ﹤0.01% |
234,829
+158,986
| +210% | +$1.29M |
|
5024
CALL
Rani Therapeutics
RANI
$99.1M
| $1.78M | ﹤0.01% |
+1,319,800
| New | +$1.99M |
|
|
NAGE
5025
PUT
Niagen Bioscience
NAGE
$254M
| $1.78M | ﹤0.01% |
+280,000
| New | +$1.95M |
|
Similar funds
Jane Street's Q4 2025 Portfolio in Review
As of Q4 2025, Jane Street held 12,943 positions worth $662B, up 0.76% from $657B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Jane Street's Q4 2025 filing shows 2,363 new, 4,318 increased, 4,192 reduced and 1,998 closed positions. Its largest new stake was iShares MSCI India ETF: 4,400,850 shares worth $238M. The largest sale was NVIDIA, an estimated $1.99B.
By sector, the portfolio is most concentrated in Technology at 2.8% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jane Street's largest Q4 2025 buy was iShares MSCI India ETF: 4,400,850 shares worth $238M.
- Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $5.55B increase.
- Jane Street's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $1.99B.
- Jane Street fully exited Applied Digital in Q4 2025, selling an estimated $207M.
- Jane Street's ten largest holdings make up 34% of its $662B portfolio in Q4 2025.
- Jane Street opened 2,363 new positions and closed 1,998 in Q4 2025.
- Jane Street's portfolio value rose 0.76% quarter-over-quarter to $662B.
Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.